ORGANIC
LETTERS
2006
Vol. 8, No. 21
4775-4778
A Strategy for the Total Synthesis of
Dragmacidin E. Construction of the
Core Ring System
Raymond J. Huntley and Raymond L. Funk*
Department of Chemistry, PennsylVania State UniVersity,
UniVersity Park, PennsylVania 16802
Received July 17, 2006
ABSTRACT
The construction of the dragmacidin core ring system by a route that features the application of a new indole annelation reaction sequence
is described.
Dragmacidins D, E, and F are an intriguing collection of
bisindole alkaloids isolated from marine sponges.1 They are
structurally more complex than the dragmacidin A, B, and
C congeners2 that lack the guanidinium functionality and
possess a piperazine linker instead of a pyrazinone between
the two indole moieties (Figure 1). It has been suggested
that dragmacidin D is the biosynthetic precursor to both
dragmacidins E and F via bond formation between C(5′′′)
and C(5)1a or C(4′′′) and C(6′′)1b, respectively. Moreover,
dragmacidins D and E displayed antibiotic activity against
E. coli (MIC ) 9 and 12 µM, respectively) and C. albicus
(MIC ) 11 and 20 µM, respectively). In addition, dragma-
cidins D and E have been reported to be potent inhibitors of
serine-threonine protein phosphatases,1a biological targets
of potential therapeutic value.3 However, in a subsequent
review,3 the protein phosphatase (PP1 and PP2a) inhibitory
activity was claimed to be quite low, although no experi-
mental evidence was provided. The promising biological
activity coupled with the challenging architecture of these
natural products has stimulated effort directed toward their
total synthesis.4 The Stoltz group is the front runner in this
endeavor and has reported the first and only syntheses of
dragmacidins D and F.4f-h The Feldman group has recently
disclosed an approach to dragmacidin E that features the
early, stereoselective construction of the cycloheptannelated
indole substructure.4i
We became interested in the synthesis of dragmacidin E
following the development of a method in our laboratories
(3) McCluskey, A.; Sim, A. T. R.; Sakoff, J. A. J. Med. Chem. 2002,
45, 1151.
(4) (a) Jiang, B.; Gu, X.-H. Bioorg. Med. Chem. 2000, 8, 363. (b) Jiang,
B.; Gu, X.-H. Heterocycles 2000, 53, 1559. (c) Yang, C.-G.; Wang, J.;
Jiang, B. Tetrahedron Lett. 2002, 43, 1063. (d) Miyake, F. Y.; Yakushijin,
K.; Horne, D. A. Org. Lett. 2002, 4, 941. (e) Yang, C.-G.; Liu, G.; Jiang,
B. J. Org. Chem. 2002, 67, 9392. (f) Garg, N. K.; Sarpong, R.; Stoltz, B.
M. J. Am. Chem. Soc. 2002, 124, 13179. (g) Garg, N. K.; Caspi, D. D.;
Stoltz, B. M. J. Am. Chem. Soc. 2004, 126, 9552. (h) Garg, N. K.; Caspi,
D. D.; Stoltz, B. M. J. Am. Chem. Soc. 2005, 127, 5970. (i) Feldman, K.
S.; Ngernmeesri, P. Org. Lett. 2005, 7, 5449.
(1) (a) Capon, R. J.; Rooney, F.; Murray, L. M.; Collins, E.; Sim, A. T.
R.; Rostas, J. A. P.; Butler, M. S.; Carroll, A. R. J. Nat. Prod. 1998, 61,
660. (b) Cutignano, A.; Bifulco, G.; Bruno, I.; Casapullo, A.; Fomez-Paloma,
L.; Riccio, R. Tetrahedron 2000, 56, 3743.
(2) (a) Kohmoto, S.; Kashman, Y.; McConnell, O. J.; Rinehart, K. L.,
Jr.; Wright, A.; Koehn, F. J. Org. Chem. 1988, 53, 3116. (b) Morris, S. A.;
Andersen, R. J. Tetrahedron 1990, 46, 715. (c) Fahy, E.; Potts, B. C. M.;
Faulkner, D. J.; Smith, K. J. Nat. Prod. 1991, 54, 564.
10.1021/ol0617547 CCC: $33.50
© 2006 American Chemical Society
Published on Web 09/15/2006